Cargando…

Micromorphological changes in cardiac tissue of drug-related deaths with emphasis on chronic illicit opioid abuse

AIMS: The main intention of this retrospective study was to investigate whether chronic illicit drug abuse, especially the intravenous use of opioids (heroin), could potentially trigger the development of myocardial fibrosis in drug addicts. DESIGN: A retrospective case–control study was performed u...

Descripción completa

Detalles Bibliográficos
Autores principales: Seltenhammer, Monika H, Marchart, Katharina, Paula, Pia, Kordina, Nicole, Klupp, Nikolaus, Schneider, Barbara, Fitzl, Christine, Risser, Daniele U
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746107/
https://www.ncbi.nlm.nih.gov/pubmed/23297783
http://dx.doi.org/10.1111/add.12106
_version_ 1782280790305931264
author Seltenhammer, Monika H
Marchart, Katharina
Paula, Pia
Kordina, Nicole
Klupp, Nikolaus
Schneider, Barbara
Fitzl, Christine
Risser, Daniele U
author_facet Seltenhammer, Monika H
Marchart, Katharina
Paula, Pia
Kordina, Nicole
Klupp, Nikolaus
Schneider, Barbara
Fitzl, Christine
Risser, Daniele U
author_sort Seltenhammer, Monika H
collection PubMed
description AIMS: The main intention of this retrospective study was to investigate whether chronic illicit drug abuse, especially the intravenous use of opioids (heroin), could potentially trigger the development of myocardial fibrosis in drug addicts. DESIGN: A retrospective case–control study was performed using myocardial tissue samples from both drug-related deaths (DRD) with verifiable opioid abuse and non-drug-related deaths in the same age group. SETTING: Department of Forensic Medicine, Medical University of Vienna, Austria (1993–94). PARTICIPANTS: Myocardial specimens were retrieved from 76 deceased intravenous opioid users and compared to those of 23 deceased non-drug users. MEASUREMENTS: Drug quantification was carried out using the enzyme-multiplied immunoassay technique (EMIT), followed by [gas chromatography–mass spectrometry (GC–MS), MAT 112®], and analysed using the Integrator 3390A by Hewlett Packard® and LABCOM.1 computer (MSS-G.G.). The amount of fibrous connective tissue (FCT) in the myocardium was determined by using the morphometric software LUCIA Net version 1.16.2(©), Laboratory Imaging, with NIS Elements 3.0®. FINDINGS: Drug analysis revealed that 67.11% were polydrug users and the same proportion was classified as heroin addicts (6-monoacetylmorphine, 6-MAM)—32.89% were users of pure heroin. In 76.32% of DRD cases, codeine was detected. Only 2.63% consumed cocaine. The mean morphine concentrations were 389.03 ng/g in the cerebellum and 275.52 ng/g in the medulla oblongata, respectively. Morphometric analysis exhibited a strong correlation between DRD and myocardial fibrosis. The mean proportion of FCT content in the drug group was 7.6 ± 2.9% (females: 6.30 ± 2.19%; males: 7.91 ± 3.01%) in contrast to 5.2 ± 1.7% (females: 4.45 ± 1.23%; males: 5.50 ± 1.78%) in the control group, indicating a significant difference (P = 0.0012), and a significant difference in the amount of FCT between females and males (P = 0.0383). There was no significant interaction of age and FCT (P = 0.8472). CONCLUSIONS: There is a long-term risk of cardiac dysfunction following chronic illicit drug abuse with opioids as a principal component. Regular cardiological examination of patients receiving substitution treatment with morphine is strongly recommended.
format Online
Article
Text
id pubmed-3746107
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-37461072013-08-20 Micromorphological changes in cardiac tissue of drug-related deaths with emphasis on chronic illicit opioid abuse Seltenhammer, Monika H Marchart, Katharina Paula, Pia Kordina, Nicole Klupp, Nikolaus Schneider, Barbara Fitzl, Christine Risser, Daniele U Addiction Research Reports AIMS: The main intention of this retrospective study was to investigate whether chronic illicit drug abuse, especially the intravenous use of opioids (heroin), could potentially trigger the development of myocardial fibrosis in drug addicts. DESIGN: A retrospective case–control study was performed using myocardial tissue samples from both drug-related deaths (DRD) with verifiable opioid abuse and non-drug-related deaths in the same age group. SETTING: Department of Forensic Medicine, Medical University of Vienna, Austria (1993–94). PARTICIPANTS: Myocardial specimens were retrieved from 76 deceased intravenous opioid users and compared to those of 23 deceased non-drug users. MEASUREMENTS: Drug quantification was carried out using the enzyme-multiplied immunoassay technique (EMIT), followed by [gas chromatography–mass spectrometry (GC–MS), MAT 112®], and analysed using the Integrator 3390A by Hewlett Packard® and LABCOM.1 computer (MSS-G.G.). The amount of fibrous connective tissue (FCT) in the myocardium was determined by using the morphometric software LUCIA Net version 1.16.2(©), Laboratory Imaging, with NIS Elements 3.0®. FINDINGS: Drug analysis revealed that 67.11% were polydrug users and the same proportion was classified as heroin addicts (6-monoacetylmorphine, 6-MAM)—32.89% were users of pure heroin. In 76.32% of DRD cases, codeine was detected. Only 2.63% consumed cocaine. The mean morphine concentrations were 389.03 ng/g in the cerebellum and 275.52 ng/g in the medulla oblongata, respectively. Morphometric analysis exhibited a strong correlation between DRD and myocardial fibrosis. The mean proportion of FCT content in the drug group was 7.6 ± 2.9% (females: 6.30 ± 2.19%; males: 7.91 ± 3.01%) in contrast to 5.2 ± 1.7% (females: 4.45 ± 1.23%; males: 5.50 ± 1.78%) in the control group, indicating a significant difference (P = 0.0012), and a significant difference in the amount of FCT between females and males (P = 0.0383). There was no significant interaction of age and FCT (P = 0.8472). CONCLUSIONS: There is a long-term risk of cardiac dysfunction following chronic illicit drug abuse with opioids as a principal component. Regular cardiological examination of patients receiving substitution treatment with morphine is strongly recommended. Blackwell Publishing Ltd 2013-07 2013-04-12 /pmc/articles/PMC3746107/ /pubmed/23297783 http://dx.doi.org/10.1111/add.12106 Text en © 2013 Society for the Study of Addiction http://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.
spellingShingle Research Reports
Seltenhammer, Monika H
Marchart, Katharina
Paula, Pia
Kordina, Nicole
Klupp, Nikolaus
Schneider, Barbara
Fitzl, Christine
Risser, Daniele U
Micromorphological changes in cardiac tissue of drug-related deaths with emphasis on chronic illicit opioid abuse
title Micromorphological changes in cardiac tissue of drug-related deaths with emphasis on chronic illicit opioid abuse
title_full Micromorphological changes in cardiac tissue of drug-related deaths with emphasis on chronic illicit opioid abuse
title_fullStr Micromorphological changes in cardiac tissue of drug-related deaths with emphasis on chronic illicit opioid abuse
title_full_unstemmed Micromorphological changes in cardiac tissue of drug-related deaths with emphasis on chronic illicit opioid abuse
title_short Micromorphological changes in cardiac tissue of drug-related deaths with emphasis on chronic illicit opioid abuse
title_sort micromorphological changes in cardiac tissue of drug-related deaths with emphasis on chronic illicit opioid abuse
topic Research Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746107/
https://www.ncbi.nlm.nih.gov/pubmed/23297783
http://dx.doi.org/10.1111/add.12106
work_keys_str_mv AT seltenhammermonikah micromorphologicalchangesincardiactissueofdrugrelateddeathswithemphasisonchronicillicitopioidabuse
AT marchartkatharina micromorphologicalchangesincardiactissueofdrugrelateddeathswithemphasisonchronicillicitopioidabuse
AT paulapia micromorphologicalchangesincardiactissueofdrugrelateddeathswithemphasisonchronicillicitopioidabuse
AT kordinanicole micromorphologicalchangesincardiactissueofdrugrelateddeathswithemphasisonchronicillicitopioidabuse
AT kluppnikolaus micromorphologicalchangesincardiactissueofdrugrelateddeathswithemphasisonchronicillicitopioidabuse
AT schneiderbarbara micromorphologicalchangesincardiactissueofdrugrelateddeathswithemphasisonchronicillicitopioidabuse
AT fitzlchristine micromorphologicalchangesincardiactissueofdrugrelateddeathswithemphasisonchronicillicitopioidabuse
AT risserdanieleu micromorphologicalchangesincardiactissueofdrugrelateddeathswithemphasisonchronicillicitopioidabuse